Edition:
India

Zoetis Inc (ZTS.N)

ZTS.N on New York Stock Exchange

82.79USD
23 Feb 2018
Change (% chg)

$2.03 (+2.51%)
Prev Close
$80.76
Open
$81.17
Day's High
$82.93
Day's Low
$81.04
Volume
596,669
Avg. Vol
701,244
52-wk High
$82.93
52-wk Low
$52.25

Select another date:

Thu, Feb 15 2018

BRIEF-Zoetis Inc Q4 Earnings Per Share $0.16

* ADJUSTED NET INCOME FOR 2017 ‍EXCLUDES ONE-TIME PROVISIONAL NET TAX CHARGE OF $212 MILLION RELATED TO RECENTLY ENACTED TAX LEGISLATION IN U.S. ​

BRIEF-Zoetis Says Preliminarily Estimated Reduction To Gaap Net Income In Q4

* ZOETIS SAYS EVALUATING IMPACT OF U.S. TAX ACT, PRELIMINARILY ESTIMATED REDUCTION TO GAAP NET INCOME IN Q4 Source text: (http://bit.ly/2qDYvyf) Further company coverage:

BRIEF-Zoetis Launches Vanguard CIV H3N2/H3N8 Vaccine For Canine Influenza Virus

* ZOETIS LAUNCHES VANGUARD CIV H3N2/H3N8 VACCINE FOR CANINE INFLUENZA VIRUS Source text for Eikon: Further company coverage:

BRIEF-Zoetis Board Approves 20% Dividend Increase

* ZOETIS DECLARES FIRST QUARTER 2018 DIVIDEND; BOARD APPROVES 20% PAYMENT INCREASE

BRIEF-Zoetis Inc Q3 earnings per share $0.61

* Q3 earnings per share view $0.62 -- Thomson Reuters I/B/E/S

BRIEF-Zoetis announces pricing of $1.25 bln of senior notes

* Zoetis Inc - ‍agreed to sell $1.25 billion of senior notes, consisting of $750 million aggregate principal amount of 3.000% senior notes due 2027​

BRIEF-Immunovaccine announces achievement of milestones in collaboration with Zoetis to develop veterinary vaccines

* Immunovaccine announces achievement of milestones in collaboration with Zoetis to develop veterinary vaccines Source text for Eikon: Further company coverage:

Select another date: